Oruka Therapeutics, Inc. (ORKA)
59.58
-4.02
(-6.32%)
USD |
NASDAQ |
Apr 10, 16:00
59.60
+0.02
(+0.03%)
After-Hours: 20:00
Oruka Therapeutics Total Assets (Quarterly) : 488.62M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CDT Equity, Inc. | 8.552M |
| LENZ Therapeutics, Inc. | 305.88M |
| Liminatus Pharma, Inc. | 0.5128M |
| Maze Therapeutics, Inc. | 397.13M |
| MapLight Therapeutics, Inc. | 479.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.69M |
| Shareholders Equity (Quarterly) | 471.93M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 22.37 |
| Net Debt Paydown Yield | -0.01% |